Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN115 fMRI study in Parkinson's disease
NCT00605553Phase 2Completed
- Sponsor
- Biotie Therapies
- Start
- Apr 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tozadenant in Parkinson's disease (PD) (2 arms), sponsored by Biotie Therapies. Primary endpoint: Clinical and fMRI response to Intravenous Levodopa at Day 7. Started Apr 2008; status: completed.
02
Drugs
tozadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00605553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605553.